Effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial
🌍 How it travelled
Newsylist detected this story across 2 language editions of the world's news.
Detected by matching proper nouns and figures that survive translation. Times reflect when each edition's coverage was first indexed.
Who reported it (5)
- Exercise and GLP-1 Agonists: Cardiovascular Benefits Beyond Weight Bioengineer.org · 48d ago
- A ‘perfect storm’ for bone loss in women: Menopause and GLP-1 weight-loss drugs UCHealth · 48d ago
- Exercise, not liraglutide alone, drives vascular gains after obesity-related weight loss News-Medical · 48d ago
- Women’s Health Wednesday: GLP-1 medication and heart health benefits NEWS10 ABC · 48d ago
- Effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial Nature · 48d ago broke it first
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
Blood Tests to Predict Alzheimer’s Are Causing Confusion and Distress
A breakthrough blood test promises earlier Alzheimer’s diagnosis, yet patients grapple with rising confusion and distress.
Column | 3 minutes of this activity may cut the risk of 13 cancers, study finds
A three‑minute burst of vigorous movement could slash the odds of thirteen cancers, upending the idea that only long workouts protect health.
Fact check: Trump makes numerous false and misleading claims about vaccines and autism
Recent coverage fact-checks numerous false vaccine and autism claims pushed by Donald Trump.
Why cyclospora keeps showing up in produce season after season
Utah reports nearly 50 cyclosporiasis cases, prompting local farmers to emphasize the importance of local produce.
Everyone's talking about hormone therapy for menopause. Should I be on it?
Hormone replacement therapy use has nearly doubled since 2017 amid new guidelines and widespread public discussion.
FDA approves 1st mRNA flu shot, from Moderna
The first mRNA-based influenza vaccine has received federal approval in the United States.